A man with prostate cancer that spread to his brain got surgery and a targeted drug
Original title: Multimodal Management of Advanced Metastatic Prostate Cancer: Excellent Response Following Resection of Brain Metastasis and 177Lu-PSMA Therapy.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a write-up of one patient, not a trial.
The short version
This is one man's story of getting better after brain surgery and a targeted drug.
What was studied. Doctors wrote up the care of one patient, a 68-year-old man. His prostate cancer had spread to his brain and his bones. They described each treatment he was given.
What they found. He first had hormone therapy and chemotherapy. A scan found a spot in the left side of his brain, and radiation did not stop it from growing. Surgeons took the spot out, and he then had 4 cycles of a drug called 177Lu-PSMA-617. After that, the cancer in his bones almost went away.
What this means, and what it doesn't
What it could mean: For some people, mixing treatments may work better than one alone. This man did well with surgery followed by the targeted drug. If your cancer has spread, you can ask your doctor if a mix like this fits your case.
What it doesn't mean: This is one person's story, not a study. One good result does not prove the treatment helps other people. Nothing here was compared to other care, so we cannot say what worked best. This is not a cure, and it does not mean the same thing will happen for you.
Source: PubMed, August 4, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.